We are live on ! Find out more
BSX icon

Boston Scientific

1,708 hedge funds and large institutions have $131B invested in Boston Scientific in 2025 Q3 according to their latest regulatory filings, with 179 funds opening new positions, 767 increasing their positions, 554 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 767 | Existing positions reduced: 554

36% more first-time investments, than exits

New positions opened: 179 | Existing positions closed: 132

14% more call options, than puts

Call options by funds: $1.13B | Put options by funds: $989M

1% more funds holding

Funds holding: 1,6871,708 (+21)

0.86% less ownership

Funds ownership: 91.53%90.67% (-0.86%)

7% less funds holding in top 10

Funds holding in top 10: 4239 (-3)

10% less capital invested

Capital invested by funds: $145B → $131B (-$14.2B)

Holders
1,708
Holders Change
+21
Holders Change %
+1.24%
% of All Funds
22.41%
Holding in Top 10
39
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-7.14%
% of All Funds
0.51%
New
179
Increased
767
Reduced
554
Closed
132
Calls
$1.13B
Puts
$989M
Net Calls
+$140M
Net Calls Change
-$85.7M
Name Holding Trade Value Shares
Change
Change in
Stake
NSEDCP
576
NJ State Employees Deferred Compensation Plan
New Jersey
$4.26M -$352K -3,400 -7%
CCM
577
Coldstream Capital Management
Washington
$4.25M +$605K +5,839 +15%
CGIM
578
Capital Group Investment Management
Singapore
$4.24M -$418K -4,032 -8%
CWP
579
Cyndeo Wealth Partners
Florida
$4.22M -$175K -1,692 -4%
LWMM
580
Legacy Wealth Management (Mississippi)
Mississippi
$4.21M -$692K -6,685 -13%
TE
581
Tema ETFs
New York
$4.19M +$2.66M +25,641 +148%
DAM
582
Deltec Asset Management
New York
$4.18M +$1.5M +14,500 +51%
NA
583
Navellier & Associates
Nevada
$4.18M -$499K -4,814 -10%
RBA
584
Richard Bernstein Advisors
New York
$4.17M -$5.3M -51,186 -55%
RF
585
Robbins Farley
New Hampshire
$4.16M +$525K +5,066 +14%
AAM
586
Advisors Asset Management
Colorado
$4.12M +$19.9K +192 +0.5%
SC
587
Saturna Capital
Washington
$4.12M +$44.5K +430 +1%
GIM
588
Generali Investments Management
Slovenia
$4.12M +$221K +2,135 +5%
SFA
589
Sequoia Financial Advisors
Ohio
$4.09M +$117K +1,125 +3%
BHC
590
Bowen Hanes & Co
Florida
$4.08M -$38.6M -372,455 -90%
KJHP
591
K.J. Harrison & Partners
Ontario, Canada
$4.08M -$1.24M -12,000 -22%
CAM
592
Costello Asset Management
Pennsylvania
$4.08M +$70.4K +680 +2%
Jones Financial Companies
593
Jones Financial Companies
Missouri
$4.08M +$994K +9,597 +30%
PCM
594
Prelude Capital Management
New York
$4.06M +$4.31M +41,610 New
GFM
595
GF Fund Management
China
$4.05M +$1.09M +10,498 +34%
TF
596
Trek Financial
Arizona
$4.03M +$822K +7,934 +24%
NP
597
Nilsine Partners
Colorado
$3.97M +$421K +4,064 +11%
BG
598
BDF Gestion
France
$3.96M +$371K +3,585 +10%
PAG
599
Private Advisor Group
New Jersey
$3.94M -$37.3K -360 -0.9%
CAM
600
Covenant Asset Management
New Jersey
$3.93M +$50.8K +491 +1%

BSX Hedge Fund Activity: Q3 2025 in Review

1,708 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2025, worth a combined $131B — down 9.8% from $145B a quarter earlier.

Buyers outnumbered sellers: 179 funds opened new BSX positions and 132 closed out — a net gain of 47 holders — while 767 added to existing stakes and 554 trimmed.

The largest buyer was Parnassus Investments, adding an estimated $711M. The largest seller was Wellington Management Group, cutting an estimated $1.86B.

  • 1,708 institutional investors held Boston Scientific (BSX) as of Q3 2025, up from 1,687 in Q2 2025.
  • Funds reported $131B of Boston Scientific stock for Q3 2025, down 9.8% quarter-over-quarter.
  • 179 funds opened new Boston Scientific positions in Q3 2025 and 132 closed out, a net change of +47 holders.
  • The largest Boston Scientific buyer in Q3 2025 was Parnassus Investments, an estimated $711M added.
  • The largest Boston Scientific seller in Q3 2025 was Wellington Management Group, an estimated $1.86B sold.

Based on aggregated 13F filings for Q3 2025.